āagman

Not investment advice. Data and computed figures, for information only.

Metropolis Healthcare Ltd

NSE: METROPOLIS
₹530.35
+₹7.35 (+1.41%)
NSE · 16 Oct 2026, close
NSE
As of 31 Mar 2026
Market Cap
₹10,980 Cr
CMP
₹530.35
52-wk High / Low
₹2,118 / 412
P/E
52.8
P/B
7.3
Book Value
₹73.0
Div Yield
0.38%
ROCE
18.0%
ROE
13.6%
Face Value
₹2
D/E
0.15

Price−73.1% over 1Y

āagman read

Computed by āagman
Derived from 12 years and 13 quarters of filings. Not reported by the company.
As of 16 Oct 2026
How we compute these
Piotroski F-Score
6
/ 9
6 of 9 F-score tests passed
Graham Number
₹123
√(22.5 × EPS × book value per share)
ROIC
11.5%
vs 11.2% sector median
Cash flow to profit
1.84
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
+135
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
10.9%
ROE × earnings retention ratio
ROE stability
4.9
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom +0.00FII +0.60DII −0.68
Latest quarter vs the previous one
Cash-accrual divergence
−8.0%
of assets
Low = accruals track cash flow
Strengths
Watch-outs
−Borrowings are up 4540% since FY2016 (5 to 232)
−Price trades below its 200-day moving average (0.6x)
−Price is 75.0% below its 52-week high
−Annualised volatility of 144.6% is in the high band (≥45%)
−Promoter holding fell by 0.9pp over the last year

Peer comparison

Peers
NameP/EMar Cap ₹ CrROCE %ROE %

Quarterly results

Consolidated basis (as filed) · ₹ Cr · 13 quarters
As of 30 Jun 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales277308291331313350323345386429406425450
Expenses214234226251235260251283296321311317339
Operating Profit63756580799072629010895108111
OPM %22.7%24.4%22.3%24.2%25.2%25.7%22.3%18.0%23.3%25.2%23.4%25.4%24.7%
Other Income3123233781085
Interest6656555556686
Depreciation21222526262728293132323932
Profit before tax39483751516142366171577078
Net Profit29362737384731294553425157
EPS (₹)1.411.731.331.781.852.271.531.412.172.542.002.462.73

Profit & Loss

As of 30 Jun 2026
Consolidated · ₹ Cr · 12 years + TTM
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales4564755456477618569981,2281,1481,2081,3311,6461,710
Expenses3393594054675596197088808559201,0231,2401,288
Operating Profit117116140181203237290348293288308406422
OPM %25.7%24.4%25.7%28.0%26.7%27.7%29.1%28.3%25.5%23.8%23.1%24.7%24.7%
Other Income7293968−171234159151614
Interest222441312253228242926
Depreciation21171719203946638994109134135
Profit before tax101128160164187169244293188175191259276
Net Profit6882107112124128183215143128146191203
EPS (₹)15.4420.1026.6127.295.996.298.9510.466.986.247.009.179.73

Balance Sheet

As of 30 Jun 2026
Consolidated · ₹ Cr
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026
Equity Capital101010101010101010101041—
Reserves3522693144054085136968769781,0861,3211,472—
Borrowings145111867112379266197204232—
Other Liabilities87107188110113160181256240254324386—
Total Liabilities4623915125265507501,0001,5211,4951,5471,8592,131—
Fixed Assets1531422022072132963431,0591,1211,1771,4471,601—
CWIP0110630620000—
Investments16810114210233141016155571142—
Other Assets141147167216298437647440340316341387—
Total Assets4623915125265507501,0001,5211,4951,5471,8592,131—

Cash Flows

As of 31 Mar 2026
Consolidated · ₹ Cr
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity699110210490215249253247264263351
Cash from Investing Activity−5696−86136−10463−73648−89−199−220
Cash from Financing Activity−9−174−17−87−118−55−33163−292−181−87−115
Net Cash Flow414−118856279−3213−6−2315

Ratios

As of 31 Mar 2026
12 periods
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %28.034.046.043.043.040.036.029.017.016.015.018.0
ROE %———————————13.6
EPS (₹)15.4420.1026.6127.295.996.298.9510.466.986.247.009.17
Book Value (₹)———————————73.0
Face Value (₹)———————————2
P/E———————————52.8
Div Yield %———————————0.38
NPM %14.716.318.317.216.115.318.117.012.310.510.811.5
OPM %26.024.026.028.027.028.029.028.026.024.023.025.0
D/E0.040.020.000.000.040.130.160.430.270.180.150.15
P/B———————————7.3

Growth

As of 11 Oct 2026
Compounded sales growth
10 years+13.0%
5 years+11.0%
3 years+13.0%
TTM+22.0%
Compounded profit growth
10 years+11.0%
5 years+1.0%
3 years+11.0%
TTM+37.0%
Stock price CAGR
5 years−5.0%
3 years+12.0%
Last year+6.0%
Return on equity
10 years19.0%
5 years15.0%
3 years12.0%
Last year14.0%

Shareholding pattern

As of 30 Jun 2025
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
Promoters56.90%56.90%50.38%49.79%49.75%49.67%48.89%48.86%48.86%
FIIs16.14%16.14%27.24%21.91%25.67%18.90%15.29%10.43%11.03%
DIIs6.10%6.10%15.73%16.20%13.64%24.86%30.30%35.80%35.12%
Government—————————
Public20.86%20.86%6.65%12.11%10.94%6.57%5.51%4.92%5.00%
No. of shareholders21,51521,51530,67979,89584,26968,28349,29349,17550,636
Change since Jun 2023 (pp)
Promoters −8.04FIIs −5.11DIIs +29.02Public −15.86

Documents

As of 11 Oct 2026
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Business Update For Q2FY27Closure of Trading WindowAnnouncement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAnnouncement under Regulation 30 (LODR)-Restructuring
Annual reports
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022
Credit ratings
Rating updateRating updateRating updateRating updateRating update
Concalls
Sep 2026TranscriptSep 2026PPTSep 2026RecordingAug 2026TranscriptAug 2026PPTAug 2026RecordingMay 2026TranscriptMay 2026PPTMay 2026RecordingFeb 2026TranscriptFeb 2026PPTNov 2025TranscriptNov 2025PPTNov 2025Recording

Corporate actions

As of 19 May 2026
19 May 2026DIVIDENDInterim Dividend - Re 1 Per Share—
20 Mar 2026BONUSBonus 3:1—
11 Nov 2025DIVIDENDInterim Dividend - Rs 4 Per Share—
17 Nov 2023DIVIDENDInterim Dividend - Rs 4 Per Share—
23 Feb 2023DIVIDENDInterim Dividend - Rs 8 Per Share—
21 Feb 2022DIVIDENDInterim Dividend - Rs. 8 Per Share—
17 Feb 2021DIVIDEND Interim Dividend - Rs 8 Per Share—
13 Feb 2020DIVIDEND Interim Dividend - Rs 8 Per Share—
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman